Matches in SemOpenAlex for { <https://semopenalex.org/work/W2076091191> ?p ?o ?g. }
- W2076091191 endingPage "7" @default.
- W2076091191 startingPage "1" @default.
- W2076091191 abstract "To investigate the long-term visual prognosis and progression of chorioretinal atrophy in patients with myopic choroidal neovascularization (mCNV) treated with intravitreal injections of bevacizumab.Hospital-based, retrospective, cross-sectional study. In total, 22 patients (22 eyes) with treatment-naïve mCNV who underwent intravitreal injection of bevacizumab and were followed up for more than 48 months were investigated. Visual acuity and fundus photographs before and 1, 2, 3, and 4 years after initial treatment in the clinics were compared and judged if chorioretinal atrophy (CRA) developed/enlarged or remained unchanged. The influence of clinical characteristics including age, sex, axial length, baseline visual acuity, CNV area, CNV location, and number of injections were investigated with logistic regression analysis.Mean logarithm of the minimum angle of resolution (logMAR) improved from 0.76 to 0.52 (P < .01), 0.48 (P < .01), and 0.54 (P < .05) after 1, 2, and 3 years, respectively. The effect slightly declined to marginally non-significant levels after 4 years (logMAR, 0.59; P = .07). CRA developed or enlarged in nine cases (41 %) in 1 year, reaching 16 cases (73 %) at the final visit. Those without CRA enlargement achieved better visual improvement. None of the aforementioned patient characteristics significantly affected CRA.Anti-VEGF therapy for mCNV is effective for vision improvement in the long term. On the other hand, development or enlargement of CRA frequently occurred, and affected visual improvement. Strategies to manage atrophy should be the next step in achieving better visual outcome upon mCNV treatment." @default.
- W2076091191 created "2016-06-24" @default.
- W2076091191 creator A5021225431 @default.
- W2076091191 creator A5028536870 @default.
- W2076091191 creator A5031918013 @default.
- W2076091191 creator A5049463882 @default.
- W2076091191 creator A5053130083 @default.
- W2076091191 creator A5066340137 @default.
- W2076091191 creator A5071690549 @default.
- W2076091191 creator A5086219366 @default.
- W2076091191 date "2012-04-19" @default.
- W2076091191 modified "2023-09-27" @default.
- W2076091191 title "Long-term effect of intravitreal injection of anti-VEGF agent for visual acuity and chorioretinal atrophy progression in myopic choroidal neovascularization" @default.
- W2076091191 cites W110906275 @default.
- W2076091191 cites W1976692135 @default.
- W2076091191 cites W1979682221 @default.
- W2076091191 cites W1987757518 @default.
- W2076091191 cites W1988457599 @default.
- W2076091191 cites W2001950796 @default.
- W2076091191 cites W2002934681 @default.
- W2076091191 cites W2006202253 @default.
- W2076091191 cites W2012138315 @default.
- W2076091191 cites W2015446470 @default.
- W2076091191 cites W2021786346 @default.
- W2076091191 cites W2023714093 @default.
- W2076091191 cites W2045532670 @default.
- W2076091191 cites W2052892208 @default.
- W2076091191 cites W2055744370 @default.
- W2076091191 cites W2057537343 @default.
- W2076091191 cites W2057953705 @default.
- W2076091191 cites W2060690838 @default.
- W2076091191 cites W2064140553 @default.
- W2076091191 cites W2065855222 @default.
- W2076091191 cites W2072119754 @default.
- W2076091191 cites W2079232091 @default.
- W2076091191 cites W2080788600 @default.
- W2076091191 cites W2082606620 @default.
- W2076091191 cites W2085039880 @default.
- W2076091191 cites W2087233702 @default.
- W2076091191 cites W2087703104 @default.
- W2076091191 cites W2091038445 @default.
- W2076091191 cites W2098670708 @default.
- W2076091191 cites W2104399871 @default.
- W2076091191 cites W2110226655 @default.
- W2076091191 cites W2116554707 @default.
- W2076091191 cites W2121744861 @default.
- W2076091191 cites W2138421229 @default.
- W2076091191 cites W2163242654 @default.
- W2076091191 cites W2323774028 @default.
- W2076091191 cites W2748001554 @default.
- W2076091191 cites W4240897419 @default.
- W2076091191 cites W4361866471 @default.
- W2076091191 doi "https://doi.org/10.1007/s00417-012-2022-8" @default.
- W2076091191 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22527326" @default.
- W2076091191 hasPublicationYear "2012" @default.
- W2076091191 type Work @default.
- W2076091191 sameAs 2076091191 @default.
- W2076091191 citedByCount "51" @default.
- W2076091191 countsByYear W20760911912013 @default.
- W2076091191 countsByYear W20760911912014 @default.
- W2076091191 countsByYear W20760911912015 @default.
- W2076091191 countsByYear W20760911912016 @default.
- W2076091191 countsByYear W20760911912017 @default.
- W2076091191 countsByYear W20760911912018 @default.
- W2076091191 countsByYear W20760911912019 @default.
- W2076091191 countsByYear W20760911912020 @default.
- W2076091191 countsByYear W20760911912021 @default.
- W2076091191 countsByYear W20760911912022 @default.
- W2076091191 countsByYear W20760911912023 @default.
- W2076091191 crossrefType "journal-article" @default.
- W2076091191 hasAuthorship W2076091191A5021225431 @default.
- W2076091191 hasAuthorship W2076091191A5028536870 @default.
- W2076091191 hasAuthorship W2076091191A5031918013 @default.
- W2076091191 hasAuthorship W2076091191A5049463882 @default.
- W2076091191 hasAuthorship W2076091191A5053130083 @default.
- W2076091191 hasAuthorship W2076091191A5066340137 @default.
- W2076091191 hasAuthorship W2076091191A5071690549 @default.
- W2076091191 hasAuthorship W2076091191A5086219366 @default.
- W2076091191 hasBestOaLocation W20760911912 @default.
- W2076091191 hasConcept C118487528 @default.
- W2076091191 hasConcept C126322002 @default.
- W2076091191 hasConcept C141071460 @default.
- W2076091191 hasConcept C167135981 @default.
- W2076091191 hasConcept C2776391266 @default.
- W2076091191 hasConcept C2776403814 @default.
- W2076091191 hasConcept C2776694085 @default.
- W2076091191 hasConcept C2777802072 @default.
- W2076091191 hasConcept C2778257484 @default.
- W2076091191 hasConcept C2781135284 @default.
- W2076091191 hasConcept C2781172350 @default.
- W2076091191 hasConcept C2781359195 @default.
- W2076091191 hasConcept C71924100 @default.
- W2076091191 hasConceptScore W2076091191C118487528 @default.
- W2076091191 hasConceptScore W2076091191C126322002 @default.
- W2076091191 hasConceptScore W2076091191C141071460 @default.
- W2076091191 hasConceptScore W2076091191C167135981 @default.
- W2076091191 hasConceptScore W2076091191C2776391266 @default.
- W2076091191 hasConceptScore W2076091191C2776403814 @default.